Published on 18/12/2025
Technical File and Design Dossier Requirements in India under the MDR 2017
In recent years, the medical device landscape in India has undergone significant changes, notably with the introduction of the Medical Device Rules (MDR) 2017. For stakeholders engaged in clinical and regulatory affairs, understanding the requirements for a technical file and design dossier is essential for compliance and successful market access of medical devices. This guide provides a step-by-step approach to navigate the critical aspects of technical documentation in India.
Understanding the Framework of India MDR 2017
The India Medical Device Rules, notified on January 31, 2017, categorize medical devices and establish the framework for their regulation, similar to those in the European Union and other jurisdictions. These rules apply to devices, diagnostics, and combination products, ensuring safety and effectiveness through stringent approval processes.
The key components of the MDR 2017 impact how clinical and regulatory teams manage documentation related to product development and compliance. The framework consists of:
- Classification of Medical Devices: Devices are classified
These foundational elements are critical for the submission of a technical file and design dossier, as they set forth the required documentation and data to support a device’s safety and efficacy.
Components of the Technical File
The technical file serves as a comprehensive compilation of documents about the medical device. It should provide evidence of compliance with applicable regulations and standards. Below are the key sections that must be included in the technical file as mandated by the India MDR.
1. Device Description
This section should provide a clear and detailed description of the device. Include information such as the intended purpose, mechanism of action, and design specifications. You should also categorize the device according to its classification (Class A, B, C, or D).
2. Design and Manufacturing Information
Document the design process through various stages, including:
- Design inputs and outputs
- Manufacturing processes
- Supplier management
It’s critical to outline how the quality of the design is maintained throughout the manufacturing process.
3. Risk Management File
Risk management is a key consideration for regulatory compliance. Manufacturers must demonstrate a systematic process for identifying risks associated with the device and outline mitigation strategies. This process is guided by ISO 14971, which details risk management throughout the lifecycle of medical devices.
4. Clinical Evaluation Report (CER)
The Clinical Evaluation Report assesses clinical data relevant to the device. If the device is novel or lacks adequate historical data, clinical studies may be required. For existing devices, the CER should compile previously obtained data demonstrating safety and efficacy.
The content of the CER should also fulfill the requirements outlined in FDA guidance documents to ensure robust comparative analysis.
5. Post-Market Surveillance (PMS) Plan
The PMS plan outlines how ongoing data related to the device will be gathered and analyzed post-approval. The plan should include:
- Types of data to be monitored
- Frequency of data collection
- Methods for responding to adverse events
6. Labeling and Instructions for Use (IFU)
Accurate labeling is critical for both compliance and user safety. This section should include the proposed labels, instructions for use, and any information users need to safely and effectively utilize the device. Compliance with standard labeling guidelines simplifies the evaluation process by regulatory authorities.
Design Dossier Elements
The design dossier is an integral part of the technical file, focusing primarily on the details of the device’s design. It should encompass more extensive documentation related to the design process than the technical file’s device description. The following elements are critical:
1. Comprehensive Development Documentation
Document all phases of product development, including initial design concepts, R&D processes, validation testing, and design changes. This will help justify the design choices made during the product lifecycle.
2. Performance Testing Data
Performance testing data is essential to demonstrate that the device meets the regulatory standards for its intended use. Testing should include:
- Bench testing
- Biocompatibility testing
- Clinical trials (if necessary)
3. Stability and Shelf-life Data
This section must provide information on the stability testing of the device under various conditions over time. Manufacturers need to illustrate how the device’s efficacy is maintained throughout its shelf life.
4. Verification and Validation (V&V) Reports
Verification and validation processes ensure the device meets specified requirements and intended uses. These reports should include methods, results, and any discrepancies that were encountered during testing.
Approval Pathways for Medical Devices in India
Understanding the approval pathways is crucial for regulatory affairs. The India MDR outlines several pathways based on device classification and risk, essential for efficient market access:
1. Class A (Low Risk) Devices
Class A devices typically require a self-declaration of conformity. While the documentation is less rigorous, a technical file must still be prepared and maintained. This includes a basic description and risk assessment, ensuring that the device conforms to essential safety requirements.
2. Class B (Low-Medium Risk) Devices
For Class B devices, the manufacturer must submit a Technical File to the CDSCO. The dossier must include comprehensive technical documentation, risk management, and clinical evaluation reports. Significant consideration must be given to PMCs to ensure ongoing compliance.
3. Class C and Class D (Medium-High Risk) Devices
Higher-risk devices (Class C and D) necessitate a more rigorous review process, requiring submission of extensive documentation, including clinical data. The approval process may involve a face-to-face meeting with regulatory authorities to address any inquiries regarding the documentation. Clinical investigations may be necessary; manufacturers should refer to the WHO guidance for clinical trials in this context.
Post-Market Surveillance and Compliance Actions
Once devices are approved and on the market, continuous vigilance is essential to maintain compliance and ensure patient safety. The post-market surveillance (PMS) obligations include:
1. Regular Monitoring and Data Collection
Establish a system for collecting data on the device’s performance post-launch. This should integrate feedback from users and healthcare professionals, ensuring that any adverse events are promptly reported and investigated.
2. Implementing Corrective and Preventive Actions (CAPA)
In the case of potential risks or identified issues, manufacturers must have a CAPA system in place to promptly address any product quality concerns. This requires documented evidence of investigations and taken corrective measures.
3. Periodic Safety Update Reports (PSUR)
Manufacturers must generate PSURs at specified intervals to provide a comprehensive overview of the benefit-risk balance of the device. These reports are crucial for evaluating ongoing product performance in the real-world setting.
Conclusion
In conclusion, adhering to the technical file and design dossier requirements under the India MDR 2017 is paramount for regulatory affairs professionals involved in medical device development and market access. A thorough understanding of the necessary components, approval pathways, and post-market obligations is critical to ensure compliance and safeguard patient safety. Regulatory consulting firms are often utilised during this process, providing expert insight and assistance, particularly in CSR medical writing, regulatory submissions, and ongoing compliance with applicable regulations.
For a successful trajectory in the Indian market, stakeholders must remain vigilant, continuously updating their technical documents to reflect changes in regulations, advancements in technology, and feedback from post-market experience.